ClinicalTrials.gov record
Recruiting Phase 2 Interventional

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

ClinicalTrials.gov ID: NCT05996003

Public ClinicalTrials.gov record NCT05996003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)

Study identification

NCT ID
NCT05996003
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
NS Pharma, Inc.
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

  • NS-089/NCNP-02 Drug

Drug

Eligibility (public fields only)

Age range
4 Years to 14 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2024
Primary completion
Sep 10, 2026
Completion
Sep 10, 2026
Last update posted
Mar 5, 2026

2024 – 2026

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Children's Hospital Colorado Aurora Colorado 80045 Recruiting
Rare Disease Research, LLC - FL Kissimmee Florida 34746 Recruiting
Rare Disease Research Atlanta Georgia 30329 Recruiting
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 Recruiting
University of Kansas Medical Center (KUMC) Kansas City Kansas 66160 Recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 Recruiting
The Children's Hospital of Philadelphia (CHOP) Philadelphia Pennsylvania 19104 Recruiting
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania 15224 Recruiting
UT Southwestern/Children's Health Dallas Texas 75207 Recruiting
Virginia Commonwealth University Health System Richmond Virginia 23298 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05996003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05996003 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →